CANASA vs YUFLYMA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. CANASA and YUFLYMA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CANASA	YUFLYMA
Rating	72/100	New
Pharmacy pays	~$26.72 /30	—
Type	RX	RX
Active ingredient	MESALAMINE	ADALIMUMAB-AATY
Manufacturer	Abbvie	Celltrion Inc
Dosage forms	Suppository	Kit
Drug class	Aminosalicylate	—
Boxed warning	None	Boxed warning
Half-life	about 7 to 9 hours (apparent terminal half-life)	—
Treats	Ulcerative Colitis, Proctitis, Sigmoid Diseases	Juvenile Arthritis, Rheumatoid Arthritis, Ulcerative Colitis

canasa yuflyma

Rating

72/100

New

Pharmacy pays

~$26.72 /30

—

Type

Active ingredient

MESALAMINE

ADALIMUMAB-AATY

Manufacturer

Abbvie

Celltrion Inc

Dosage forms

Suppository

Kit

Drug class

Aminosalicylate

—

Boxed warning

None

Boxed warning

Half-life

about 7 to 9 hours (apparent terminal half-life)

—

Treats

Ulcerative Colitis, Proctitis, Sigmoid Diseases

Juvenile Arthritis, Rheumatoid Arthritis, Ulcerative Colitis

Frequently asked questions

What is the difference between Canasa and Yuflyma?

Canasa contains Mesalamine, while Yuflyma contains Adalimumab-Aaty — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.